| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 21 | 2023 | 277 | 6.420 |
Why?
|
| Trypanosoma cruzi | 15 | 2023 | 221 | 5.580 |
Why?
|
| Pregnancy Outcome | 46 | 2021 | 643 | 5.130 |
Why?
|
| Pregnancy | 203 | 2024 | 7573 | 4.750 |
Why?
|
| Prenatal Care | 51 | 2022 | 325 | 4.340 |
Why?
|
| Cyclonic Storms | 13 | 2020 | 88 | 3.390 |
Why?
|
| Premature Birth | 27 | 2023 | 407 | 3.200 |
Why?
|
| Pregnancy Complications | 24 | 2017 | 526 | 3.200 |
Why?
|
| Pregnancy Complications, Infectious | 15 | 2023 | 419 | 3.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 12 | 2021 | 234 | 3.160 |
Why?
|
| Disasters | 12 | 2017 | 107 | 3.090 |
Why?
|
| Developing Countries | 31 | 2023 | 315 | 2.940 |
Why?
|
| Infant, Low Birth Weight | 28 | 2023 | 181 | 2.400 |
Why?
|
| Maternal Health Services | 13 | 2013 | 34 | 2.350 |
Why?
|
| Infant Mortality | 35 | 2020 | 186 | 2.280 |
Why?
|
| Pregnancy Complications, Parasitic | 7 | 2023 | 22 | 2.080 |
Why?
|
| Diabetes, Gestational | 6 | 2017 | 104 | 2.080 |
Why?
|
| Infant, Newborn | 96 | 2023 | 8223 | 2.040 |
Why?
|
| Delivery, Obstetric | 21 | 2020 | 227 | 1.900 |
Why?
|
| Zika Virus Infection | 7 | 2023 | 166 | 1.890 |
Why?
|
| Public Health | 8 | 2020 | 299 | 1.770 |
Why?
|
| Pregnant Women | 11 | 2022 | 162 | 1.770 |
Why?
|
| Louisiana | 19 | 2022 | 139 | 1.690 |
Why?
|
| Periodontal Diseases | 8 | 2015 | 22 | 1.690 |
Why?
|
| Birth Weight | 28 | 2023 | 374 | 1.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2015 | 604 | 1.540 |
Why?
|
| Vaccines | 4 | 2023 | 389 | 1.490 |
Why?
|
| Female | 221 | 2024 | 141928 | 1.450 |
Why?
|
| Petroleum Pollution | 3 | 2021 | 4 | 1.450 |
Why?
|
| Syphilis | 5 | 2022 | 61 | 1.430 |
Why?
|
| Antibodies, Protozoan | 6 | 2021 | 87 | 1.390 |
Why?
|
| Global Health | 13 | 2018 | 657 | 1.340 |
Why?
|
| Mental Health | 7 | 2014 | 415 | 1.330 |
Why?
|
| Cesarean Section | 14 | 2020 | 367 | 1.330 |
Why?
|
| Maternal Mortality | 19 | 2014 | 77 | 1.260 |
Why?
|
| Obstetric Labor, Premature | 14 | 2016 | 80 | 1.170 |
Why?
|
| Mothers | 9 | 2019 | 410 | 1.170 |
Why?
|
| Postpartum Hemorrhage | 10 | 2013 | 81 | 1.170 |
Why?
|
| Humans | 253 | 2024 | 261506 | 1.140 |
Why?
|
| Gestational Age | 26 | 2021 | 1069 | 1.130 |
Why?
|
| Zika Virus | 4 | 2023 | 144 | 1.070 |
Why?
|
| Birth Rate | 3 | 2020 | 17 | 1.060 |
Why?
|
| Nitroimidazoles | 3 | 2020 | 100 | 1.050 |
Why?
|
| Stress, Psychological | 6 | 2019 | 1000 | 1.030 |
Why?
|
| Dengue | 4 | 2014 | 109 | 1.020 |
Why?
|
| Perinatal Mortality | 8 | 2013 | 41 | 1.020 |
Why?
|
| Parturition | 4 | 2024 | 65 | 0.970 |
Why?
|
| Argentina | 24 | 2020 | 72 | 0.950 |
Why?
|
| Depression, Postpartum | 5 | 2010 | 45 | 0.950 |
Why?
|
| Maternal Welfare | 6 | 2012 | 14 | 0.940 |
Why?
|
| Trypanosoma | 1 | 2023 | 10 | 0.930 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2023 | 268 | 0.930 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2024 | 87 | 0.890 |
Why?
|
| Microcephaly | 4 | 2021 | 325 | 0.890 |
Why?
|
| Environmental Exposure | 3 | 2017 | 288 | 0.890 |
Why?
|
| Periodontitis | 5 | 2013 | 18 | 0.870 |
Why?
|
| Craniosynostoses | 1 | 2023 | 98 | 0.850 |
Why?
|
| Mexico | 11 | 2020 | 259 | 0.850 |
Why?
|
| Socioeconomic Factors | 15 | 2019 | 1225 | 0.850 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 651 | 0.840 |
Why?
|
| Belgium | 29 | 2020 | 47 | 0.830 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 715 | 0.830 |
Why?
|
| Parity | 11 | 2019 | 139 | 0.830 |
Why?
|
| Stillbirth | 11 | 2016 | 82 | 0.810 |
Why?
|
| Maternal Exposure | 3 | 2022 | 160 | 0.800 |
Why?
|
| Midwifery | 9 | 2019 | 38 | 0.800 |
Why?
|
| Perinatal Care | 5 | 2019 | 63 | 0.790 |
Why?
|
| Women's Health | 5 | 2019 | 205 | 0.780 |
Why?
|
| Adult | 101 | 2021 | 77950 | 0.780 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2019 | 59 | 0.770 |
Why?
|
| Maternal Age | 9 | 2016 | 152 | 0.750 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 1489 | 0.740 |
Why?
|
| Home Childbirth | 6 | 2013 | 38 | 0.730 |
Why?
|
| Population Surveillance | 8 | 2020 | 627 | 0.710 |
Why?
|
| Abortion, Spontaneous | 5 | 2017 | 112 | 0.680 |
Why?
|
| Metals | 1 | 2019 | 155 | 0.670 |
Why?
|
| Risk Factors | 41 | 2020 | 17523 | 0.660 |
Why?
|
| Syphilis, Congenital | 4 | 2022 | 25 | 0.650 |
Why?
|
| Oxytocin | 5 | 2011 | 62 | 0.650 |
Why?
|
| Infant | 29 | 2023 | 13310 | 0.650 |
Why?
|
| Zambia | 9 | 2023 | 26 | 0.640 |
Why?
|
| Protozoan Vaccines | 1 | 2019 | 91 | 0.640 |
Why?
|
| Public Health Administration | 1 | 2017 | 13 | 0.620 |
Why?
|
| Oxytocics | 4 | 2010 | 27 | 0.620 |
Why?
|
| Review Literature as Topic | 2 | 2008 | 71 | 0.620 |
Why?
|
| Evidence-Based Medicine | 9 | 2016 | 1085 | 0.600 |
Why?
|
| Biomedical Research | 3 | 2020 | 806 | 0.600 |
Why?
|
| Uruguay | 13 | 2023 | 15 | 0.600 |
Why?
|
| Logistic Models | 15 | 2019 | 3441 | 0.590 |
Why?
|
| Young Adult | 43 | 2021 | 21445 | 0.580 |
Why?
|
| Fetal Blood | 7 | 2022 | 482 | 0.580 |
Why?
|
| Fertilization in Vitro | 2 | 2017 | 199 | 0.580 |
Why?
|
| Disease Transmission, Infectious | 1 | 2017 | 94 | 0.570 |
Why?
|
| Prospective Studies | 29 | 2021 | 12873 | 0.560 |
Why?
|
| Obstetrics | 8 | 2013 | 221 | 0.550 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2015 | 173 | 0.550 |
Why?
|
| Depression | 5 | 2012 | 1715 | 0.550 |
Why?
|
| Birth Certificates | 5 | 2013 | 24 | 0.550 |
Why?
|
| Health Services Accessibility | 10 | 2020 | 761 | 0.550 |
Why?
|
| Validation Studies as Topic | 1 | 2015 | 43 | 0.540 |
Why?
|
| Serologic Tests | 3 | 2021 | 137 | 0.540 |
Why?
|
| Infertility | 1 | 2017 | 123 | 0.540 |
Why?
|
| Apgar Score | 4 | 2020 | 55 | 0.530 |
Why?
|
| Maternal Health | 3 | 2021 | 19 | 0.530 |
Why?
|
| Vomiting | 1 | 2017 | 354 | 0.530 |
Why?
|
| Prevalence | 12 | 2020 | 3260 | 0.530 |
Why?
|
| Adolescent | 47 | 2022 | 31252 | 0.520 |
Why?
|
| Glucocorticoids | 5 | 2016 | 629 | 0.520 |
Why?
|
| Nausea | 1 | 2017 | 525 | 0.520 |
Why?
|
| Poverty | 3 | 2014 | 471 | 0.510 |
Why?
|
| Tropical Medicine | 2 | 2014 | 105 | 0.500 |
Why?
|
| Indians, South American | 1 | 2014 | 14 | 0.500 |
Why?
|
| Encephalitis, St. Louis | 1 | 2014 | 21 | 0.500 |
Why?
|
| Chikungunya Fever | 1 | 2014 | 24 | 0.490 |
Why?
|
| Vaccination | 6 | 2023 | 1123 | 0.480 |
Why?
|
| Labor Stage, Third | 6 | 2011 | 6 | 0.480 |
Why?
|
| Perception | 2 | 2015 | 350 | 0.480 |
Why?
|
| Surveys and Questionnaires | 15 | 2017 | 5687 | 0.480 |
Why?
|
| Emigrants and Immigrants | 2 | 2012 | 147 | 0.470 |
Why?
|
| Risk Assessment | 8 | 2020 | 6869 | 0.470 |
Why?
|
| Meta-Analysis as Topic | 3 | 2023 | 276 | 0.460 |
Why?
|
| Postpartum Period | 4 | 2020 | 259 | 0.460 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 348 | 0.450 |
Why?
|
| Periodontal Index | 4 | 2013 | 4 | 0.440 |
Why?
|
| Periodontal Pocket | 4 | 2013 | 5 | 0.440 |
Why?
|
| Periodontal Attachment Loss | 4 | 2013 | 5 | 0.440 |
Why?
|
| Universities | 2 | 2017 | 160 | 0.440 |
Why?
|
| Obstetric Labor Complications | 6 | 2019 | 95 | 0.440 |
Why?
|
| Disaster Planning | 3 | 2009 | 68 | 0.440 |
Why?
|
| Adaptation, Psychological | 3 | 2015 | 764 | 0.430 |
Why?
|
| Pandemics | 4 | 2024 | 1559 | 0.430 |
Why?
|
| Mexican Americans | 4 | 2017 | 322 | 0.430 |
Why?
|
| Smoking Cessation | 6 | 2016 | 712 | 0.420 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 84 | 0.420 |
Why?
|
| Reproduction | 1 | 2014 | 253 | 0.420 |
Why?
|
| Schools, Public Health | 1 | 2011 | 5 | 0.410 |
Why?
|
| Social Class | 7 | 2017 | 310 | 0.410 |
Why?
|
| Acculturation | 4 | 2016 | 112 | 0.410 |
Why?
|
| Education, Graduate | 1 | 2011 | 24 | 0.410 |
Why?
|
| Safety Management | 2 | 2012 | 132 | 0.410 |
Why?
|
| Infant, Premature | 10 | 2018 | 787 | 0.410 |
Why?
|
| Schools, Medical | 1 | 2012 | 132 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 1209 | 0.400 |
Why?
|
| HIV Infections | 3 | 2020 | 2134 | 0.400 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2016 | 544 | 0.400 |
Why?
|
| Emblems and Insignia | 1 | 2011 | 1 | 0.400 |
Why?
|
| Honduras | 5 | 2021 | 21 | 0.400 |
Why?
|
| Twins | 6 | 2002 | 70 | 0.390 |
Why?
|
| Internationality | 2 | 2016 | 208 | 0.390 |
Why?
|
| Competency-Based Education | 1 | 2011 | 72 | 0.390 |
Why?
|
| Educational Status | 8 | 2016 | 397 | 0.390 |
Why?
|
| Health Services Needs and Demand | 4 | 2020 | 244 | 0.380 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 273 | 0.380 |
Why?
|
| Cohort Studies | 14 | 2023 | 9244 | 0.380 |
Why?
|
| Health Status | 2 | 2012 | 590 | 0.380 |
Why?
|
| Battered Women | 1 | 2010 | 5 | 0.380 |
Why?
|
| Mississippi | 3 | 2020 | 26 | 0.380 |
Why?
|
| Obesity | 2 | 2013 | 2884 | 0.380 |
Why?
|
| Infant Health | 2 | 2021 | 17 | 0.380 |
Why?
|
| Perinatal Death | 3 | 2016 | 31 | 0.380 |
Why?
|
| United States | 27 | 2022 | 15433 | 0.370 |
Why?
|
| Delivery of Health Care | 5 | 2024 | 860 | 0.370 |
Why?
|
| Spouse Abuse | 1 | 2010 | 21 | 0.370 |
Why?
|
| Misoprostol | 1 | 2010 | 19 | 0.370 |
Why?
|
| Patient Care Planning | 1 | 2012 | 297 | 0.370 |
Why?
|
| Child Health Services | 1 | 2011 | 82 | 0.360 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 4 | 2007 | 14 | 0.360 |
Why?
|
| Puerperal Infection | 3 | 2015 | 8 | 0.360 |
Why?
|
| Crime Victims | 1 | 2010 | 59 | 0.350 |
Why?
|
| Trypanocidal Agents | 2 | 2019 | 26 | 0.340 |
Why?
|
| Income | 4 | 2022 | 222 | 0.340 |
Why?
|
| Relief Work | 1 | 2008 | 26 | 0.330 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2016 | 105 | 0.330 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 4314 | 0.320 |
Why?
|
| Episiotomy | 5 | 2009 | 17 | 0.320 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 290 | 0.310 |
Why?
|
| Latin America | 9 | 2020 | 115 | 0.310 |
Why?
|
| Hypertension | 2 | 2017 | 1503 | 0.310 |
Why?
|
| Health Personnel | 4 | 2021 | 625 | 0.310 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 338 | 0.310 |
Why?
|
| Body Mass Index | 5 | 2013 | 2203 | 0.310 |
Why?
|
| Social Support | 6 | 2012 | 560 | 0.300 |
Why?
|
| Health Status Disparities | 1 | 2010 | 291 | 0.300 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 1054 | 0.300 |
Why?
|
| Registries | 13 | 2018 | 2170 | 0.290 |
Why?
|
| Emigration and Immigration | 5 | 2010 | 86 | 0.290 |
Why?
|
| Odds Ratio | 10 | 2015 | 2316 | 0.280 |
Why?
|
| Seroepidemiologic Studies | 3 | 2015 | 129 | 0.280 |
Why?
|
| Self Report | 4 | 2021 | 756 | 0.280 |
Why?
|
| Africa South of the Sahara | 5 | 2018 | 101 | 0.270 |
Why?
|
| Pregnancy, Multiple | 5 | 2017 | 45 | 0.270 |
Why?
|
| Breech Presentation | 3 | 2020 | 22 | 0.270 |
Why?
|
| Clinical Competence | 2 | 2011 | 1270 | 0.270 |
Why?
|
| New Orleans | 3 | 2015 | 14 | 0.270 |
Why?
|
| Counseling | 4 | 2015 | 381 | 0.260 |
Why?
|
| Prenatal Diagnosis | 7 | 2021 | 590 | 0.260 |
Why?
|
| Clinical Laboratory Techniques | 3 | 2020 | 203 | 0.260 |
Why?
|
| Gynecology | 2 | 1998 | 217 | 0.250 |
Why?
|
| Child Welfare | 1 | 2005 | 66 | 0.250 |
Why?
|
| Anxiety | 3 | 2016 | 1179 | 0.250 |
Why?
|
| Smoking | 6 | 2016 | 2440 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 2594 | 0.240 |
Why?
|
| Classification | 1 | 2024 | 41 | 0.240 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 56 | 0.240 |
Why?
|
| Case-Control Studies | 7 | 2016 | 6100 | 0.240 |
Why?
|
| Text Messaging | 2 | 2015 | 35 | 0.240 |
Why?
|
| C-Peptide | 1 | 2003 | 107 | 0.230 |
Why?
|
| Rwanda | 1 | 2023 | 7 | 0.230 |
Why?
|
| Aluminum | 1 | 2023 | 19 | 0.230 |
Why?
|
| West Nile Fever | 2 | 2016 | 151 | 0.230 |
Why?
|
| Weight Gain | 1 | 2006 | 464 | 0.230 |
Why?
|
| Quality Improvement | 3 | 2019 | 851 | 0.230 |
Why?
|
| Uganda | 1 | 2023 | 74 | 0.220 |
Why?
|
| Mental Disorders | 1 | 2010 | 862 | 0.220 |
Why?
|
| Data Accuracy | 1 | 2023 | 54 | 0.220 |
Why?
|
| Delivery Rooms | 2 | 2013 | 14 | 0.220 |
Why?
|
| Pediatrics | 1 | 2012 | 1141 | 0.220 |
Why?
|
| Contraceptives, Oral | 4 | 1991 | 55 | 0.220 |
Why?
|
| Democratic Republic of the Congo | 7 | 2019 | 14 | 0.220 |
Why?
|
| Morbidity | 2 | 2022 | 397 | 0.220 |
Why?
|
| Research Design | 6 | 2019 | 1544 | 0.210 |
Why?
|
| Neonatology | 3 | 2013 | 42 | 0.210 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 4971 | 0.210 |
Why?
|
| Awareness | 2 | 2021 | 126 | 0.210 |
Why?
|
| Trichomonas vaginalis | 1 | 2021 | 10 | 0.200 |
Why?
|
| Trichomonas Vaginitis | 1 | 2021 | 18 | 0.200 |
Why?
|
| Pre-Eclampsia | 4 | 2010 | 212 | 0.200 |
Why?
|
| Child Development | 1 | 2023 | 255 | 0.200 |
Why?
|
| Child | 11 | 2023 | 29154 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2016 | 573 | 0.200 |
Why?
|
| Extraction, Obstetrical | 1 | 2001 | 7 | 0.200 |
Why?
|
| Mass Screening | 5 | 2021 | 1509 | 0.200 |
Why?
|
| Health Promotion | 2 | 2010 | 502 | 0.200 |
Why?
|
| Treponema pallidum | 1 | 2021 | 29 | 0.200 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 100 | 0.200 |
Why?
|
| Observation | 1 | 2001 | 48 | 0.190 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 42 | 0.190 |
Why?
|
| Decision Making | 3 | 2017 | 1287 | 0.190 |
Why?
|
| Alabama | 1 | 2020 | 39 | 0.190 |
Why?
|
| Quality of Health Care | 6 | 2010 | 621 | 0.190 |
Why?
|
| Parasite Load | 1 | 2020 | 32 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 630 | 0.190 |
Why?
|
| Health Information Systems | 1 | 2021 | 34 | 0.190 |
Why?
|
| Comorbidity | 4 | 2020 | 2352 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2008 | 1303 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2012 | 441 | 0.190 |
Why?
|
| Europe | 6 | 2003 | 649 | 0.190 |
Why?
|
| Hospitals | 3 | 2013 | 485 | 0.180 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2019 | 14 | 0.180 |
Why?
|
| Maternal-Child Health Services | 1 | 2019 | 14 | 0.180 |
Why?
|
| Cephalometry | 1 | 2019 | 39 | 0.180 |
Why?
|
| History, 20th Century | 2 | 2012 | 574 | 0.180 |
Why?
|
| Incidence | 7 | 2021 | 5673 | 0.180 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 124 | 0.180 |
Why?
|
| Mercury | 1 | 2019 | 32 | 0.180 |
Why?
|
| Cadmium | 1 | 2019 | 57 | 0.180 |
Why?
|
| Dried Blood Spot Testing | 1 | 2019 | 21 | 0.180 |
Why?
|
| Fetus | 2 | 2023 | 601 | 0.180 |
Why?
|
| Placenta | 1 | 2003 | 516 | 0.180 |
Why?
|
| Pregnancy Rate | 2 | 2017 | 58 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 657 | 0.170 |
Why?
|
| Bias | 6 | 2006 | 205 | 0.170 |
Why?
|
| Motivation | 3 | 2015 | 499 | 0.170 |
Why?
|
| Guideline Adherence | 5 | 2013 | 636 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 242 | 0.170 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2021 | 47 | 0.170 |
Why?
|
| Viral Plaque Assay | 1 | 2018 | 48 | 0.170 |
Why?
|
| North Carolina | 5 | 2006 | 125 | 0.160 |
Why?
|
| Pregnancy Trimester, First | 4 | 2013 | 127 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 2 | 2011 | 245 | 0.160 |
Why?
|
| Labor, Obstetric | 3 | 1995 | 86 | 0.160 |
Why?
|
| Rural Population | 3 | 2015 | 281 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 403 | 0.160 |
Why?
|
| Fetal Development | 1 | 2019 | 120 | 0.160 |
Why?
|
| Gulf of Mexico | 1 | 2017 | 4 | 0.160 |
Why?
|
| Marital Status | 3 | 2009 | 98 | 0.160 |
Why?
|
| Residence Characteristics | 5 | 2010 | 348 | 0.160 |
Why?
|
| Neutralization Tests | 1 | 2018 | 299 | 0.160 |
Why?
|
| Middle Aged | 15 | 2017 | 86204 | 0.150 |
Why?
|
| World Health Organization | 2 | 2018 | 316 | 0.150 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 4298 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 14889 | 0.150 |
Why?
|
| Focus Groups | 4 | 2021 | 256 | 0.150 |
Why?
|
| Fertilization | 1 | 2017 | 56 | 0.150 |
Why?
|
| Neglected Diseases | 1 | 2020 | 147 | 0.150 |
Why?
|
| Congenital Abnormalities | 3 | 2016 | 260 | 0.150 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 415 | 0.150 |
Why?
|
| Mentors | 1 | 2019 | 203 | 0.150 |
Why?
|
| Regression Analysis | 4 | 2010 | 1546 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 4320 | 0.150 |
Why?
|
| Pregnancy in Adolescence | 2 | 2015 | 58 | 0.150 |
Why?
|
| Africa | 6 | 2016 | 142 | 0.150 |
Why?
|
| Phylogeny | 1 | 2019 | 826 | 0.150 |
Why?
|
| Intrauterine Devices | 2 | 1995 | 19 | 0.150 |
Why?
|
| Pregnancy, Twin | 2 | 2014 | 118 | 0.150 |
Why?
|
| Retrospective Studies | 13 | 2020 | 37905 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2017 | 42 | 0.150 |
Why?
|
| England | 2 | 2012 | 75 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 4 | 2019 | 585 | 0.140 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 11 | 0.140 |
Why?
|
| Qualitative Research | 5 | 2021 | 556 | 0.140 |
Why?
|
| Diagnosis | 1 | 2016 | 34 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 1217 | 0.140 |
Why?
|
| Epidemiologic Methods | 3 | 1995 | 254 | 0.140 |
Why?
|
| Evaluation Studies as Topic | 2 | 2015 | 418 | 0.140 |
Why?
|
| Intensive Care, Neonatal | 1 | 2016 | 53 | 0.140 |
Why?
|
| Cetylpyridinium | 1 | 2015 | 1 | 0.140 |
Why?
|
| Oral Health | 1 | 2015 | 18 | 0.140 |
Why?
|
| Guatemala | 5 | 2014 | 67 | 0.140 |
Why?
|
| Pakistan | 5 | 2014 | 77 | 0.140 |
Why?
|
| Mouthwashes | 1 | 2015 | 41 | 0.140 |
Why?
|
| Fear | 1 | 2017 | 254 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2023 | 2218 | 0.130 |
Why?
|
| Tetanus Toxoid | 2 | 1995 | 43 | 0.130 |
Why?
|
| Menstruation | 2 | 2007 | 39 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 635 | 0.130 |
Why?
|
| Perineum | 2 | 1987 | 107 | 0.130 |
Why?
|
| Checklist | 1 | 2016 | 122 | 0.130 |
Why?
|
| Research Report | 1 | 2016 | 144 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 980 | 0.130 |
Why?
|
| Body Weights and Measures | 1 | 2015 | 52 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 1995 | 78 | 0.130 |
Why?
|
| Clinical Coding | 1 | 2015 | 28 | 0.130 |
Why?
|
| Africa, Northern | 4 | 2004 | 12 | 0.130 |
Why?
|
| India | 5 | 2014 | 301 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 6 | 2016 | 2403 | 0.130 |
Why?
|
| Patient Preference | 1 | 2017 | 218 | 0.130 |
Why?
|
| Intention | 1 | 2015 | 109 | 0.130 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 918 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.130 |
Why?
|
| Tetanus | 1 | 1995 | 25 | 0.130 |
Why?
|
| Cotinine | 1 | 2014 | 41 | 0.130 |
Why?
|
| Male | 21 | 2019 | 123000 | 0.130 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 121 | 0.130 |
Why?
|
| Leadership | 1 | 2017 | 254 | 0.120 |
Why?
|
| Wounds and Injuries | 2 | 2011 | 399 | 0.120 |
Why?
|
| Southeastern United States | 1 | 2014 | 54 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2019 | 492 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2019 | 16273 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 309 | 0.120 |
Why?
|
| Education, Public Health Professional | 1 | 2014 | 3 | 0.120 |
Why?
|
| Analgesia, Obstetrical | 1 | 1994 | 10 | 0.120 |
Why?
|
| Dental Prophylaxis | 1 | 2013 | 6 | 0.120 |
Why?
|
| Tropical Climate | 1 | 2014 | 51 | 0.120 |
Why?
|
| Breast Feeding | 1 | 2015 | 239 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2009 | 465 | 0.120 |
Why?
|
| Kenya | 4 | 2014 | 46 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2021 | 925 | 0.120 |
Why?
|
| Sleep | 1 | 2017 | 413 | 0.120 |
Why?
|
| Infertility, Male | 1 | 2017 | 297 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2017 | 2292 | 0.120 |
Why?
|
| Infant Care | 2 | 2010 | 48 | 0.120 |
Why?
|
| Communication | 2 | 2017 | 876 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 4892 | 0.110 |
Why?
|
| Tobacco Use Cessation | 1 | 2013 | 28 | 0.110 |
Why?
|
| Thinness | 1 | 2013 | 82 | 0.110 |
Why?
|
| Epidemics | 1 | 2013 | 63 | 0.110 |
Why?
|
| Life Change Events | 2 | 2004 | 83 | 0.110 |
Why?
|
| Hospitals, Public | 3 | 2010 | 64 | 0.110 |
Why?
|
| Sex Education | 1 | 1993 | 26 | 0.110 |
Why?
|
| Health Surveys | 3 | 2010 | 402 | 0.110 |
Why?
|
| Rubella | 2 | 1983 | 22 | 0.110 |
Why?
|
| Gingival Hemorrhage | 1 | 2012 | 1 | 0.110 |
Why?
|
| Gingival Recession | 1 | 2012 | 1 | 0.110 |
Why?
|
| Immunization | 1 | 1995 | 397 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 284 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 6009 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 1994 | 253 | 0.110 |
Why?
|
| Altitude | 1 | 2013 | 39 | 0.110 |
Why?
|
| Health Behavior | 2 | 2009 | 603 | 0.110 |
Why?
|
| Professional Competence | 1 | 2014 | 136 | 0.110 |
Why?
|
| AIDS Serodiagnosis | 1 | 2013 | 61 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 213 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2016 | 479 | 0.110 |
Why?
|
| Health Communication | 1 | 2012 | 37 | 0.110 |
Why?
|
| Antiprotozoal Agents | 1 | 2012 | 40 | 0.100 |
Why?
|
| Puerto Rico | 3 | 2016 | 65 | 0.100 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2003 | 29 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 901 | 0.100 |
Why?
|
| Asia | 3 | 2016 | 142 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 502 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 154 | 0.100 |
Why?
|
| History, 15th Century | 1 | 2011 | 16 | 0.100 |
Why?
|
| Developed Countries | 1 | 2011 | 42 | 0.100 |
Why?
|
| Endemic Diseases | 2 | 2008 | 67 | 0.100 |
Why?
|
| Fasting | 1 | 2012 | 349 | 0.100 |
Why?
|
| Fetal Death | 2 | 2010 | 113 | 0.100 |
Why?
|
| Community Networks | 1 | 2010 | 45 | 0.100 |
Why?
|
| Health Services Research | 3 | 2008 | 233 | 0.100 |
Why?
|
| Mother-Child Relations | 2 | 2010 | 81 | 0.090 |
Why?
|
| Drug Utilization | 3 | 2016 | 179 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 598 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 667 | 0.090 |
Why?
|
| Finland | 6 | 2006 | 55 | 0.090 |
Why?
|
| Inservice Training | 1 | 2010 | 78 | 0.090 |
Why?
|
| Uterus | 1 | 2015 | 678 | 0.090 |
Why?
|
| Nursing Methodology Research | 1 | 2009 | 18 | 0.090 |
Why?
|
| Insurance, Dental | 1 | 2009 | 1 | 0.090 |
Why?
|
| Rural Health | 2 | 2016 | 51 | 0.090 |
Why?
|
| Dental Care | 1 | 2009 | 15 | 0.090 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 118 | 0.090 |
Why?
|
| Oral Hygiene | 1 | 2009 | 20 | 0.090 |
Why?
|
| Perinatology | 1 | 1990 | 31 | 0.090 |
Why?
|
| Cause of Death | 6 | 2010 | 752 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 674 | 0.090 |
Why?
|
| Sexual Partners | 1 | 2010 | 112 | 0.090 |
Why?
|
| Interviews as Topic | 3 | 2016 | 497 | 0.090 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2010 | 165 | 0.090 |
Why?
|
| Umbilical Cord | 1 | 2009 | 54 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2006 | 899 | 0.090 |
Why?
|
| Preventive Health Services | 2 | 2006 | 75 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2011 | 255 | 0.080 |
Why?
|
| Family Planning Services | 1 | 1988 | 35 | 0.080 |
Why?
|
| Body Weight | 1 | 2013 | 1293 | 0.080 |
Why?
|
| Curriculum | 2 | 2011 | 860 | 0.080 |
Why?
|
| Cultural Characteristics | 2 | 2004 | 70 | 0.080 |
Why?
|
| Epidemiologic Studies | 2 | 2016 | 60 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2008 | 70 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 756 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 1991 | 289 | 0.080 |
Why?
|
| Resuscitation | 1 | 2010 | 223 | 0.080 |
Why?
|
| Time Factors | 7 | 2016 | 12926 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 1988 | 118 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2012 | 1244 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 429 | 0.080 |
Why?
|
| Ultrasonography | 3 | 1991 | 1863 | 0.080 |
Why?
|
| Hospital Departments | 1 | 1987 | 15 | 0.080 |
Why?
|
| Urban Population | 3 | 2015 | 269 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2012 | 1450 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2013 | 430 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1323 | 0.070 |
Why?
|
| Aid to Families with Dependent Children | 1 | 2006 | 2 | 0.070 |
Why?
|
| Maternal-Child Health Centers | 1 | 2006 | 6 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2012 | 731 | 0.070 |
Why?
|
| French Guiana | 2 | 2018 | 2 | 0.070 |
Why?
|
| France | 5 | 2006 | 108 | 0.070 |
Why?
|
| Genotype | 1 | 2015 | 4109 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1454 | 0.070 |
Why?
|
| North America | 1 | 2007 | 314 | 0.070 |
Why?
|
| Food Services | 1 | 2006 | 38 | 0.070 |
Why?
|
| Meperidine | 1 | 2006 | 9 | 0.070 |
Why?
|
| Labor Pain | 1 | 2006 | 3 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 551 | 0.070 |
Why?
|
| Massachusetts | 3 | 2016 | 106 | 0.070 |
Why?
|
| Anemia | 2 | 2003 | 689 | 0.070 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 72 | 0.070 |
Why?
|
| Private Practice | 1 | 1986 | 31 | 0.070 |
Why?
|
| Pregnancy, High-Risk | 3 | 2006 | 49 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 251 | 0.070 |
Why?
|
| Hospitals, Maternity | 3 | 2011 | 9 | 0.070 |
Why?
|
| Neonatal Screening | 1 | 2007 | 165 | 0.070 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 78 | 0.070 |
Why?
|
| China | 4 | 2015 | 606 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 1819 | 0.070 |
Why?
|
| Dengue Virus | 2 | 2018 | 123 | 0.070 |
Why?
|
| Age Distribution | 2 | 2006 | 698 | 0.060 |
Why?
|
| Homicide | 1 | 2005 | 36 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2008 | 272 | 0.060 |
Why?
|
| Vagina | 2 | 1990 | 317 | 0.060 |
Why?
|
| Acidosis | 1 | 2006 | 116 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2006 | 250 | 0.060 |
Why?
|
| Anthropometry | 2 | 2016 | 269 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 305 | 0.060 |
Why?
|
| Problem Solving | 1 | 2004 | 85 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2006 | 2307 | 0.060 |
Why?
|
| Papio | 1 | 1983 | 70 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2003 | 170 | 0.060 |
Why?
|
| ROC Curve | 2 | 2018 | 1183 | 0.060 |
Why?
|
| Risk | 4 | 2013 | 1972 | 0.060 |
Why?
|
| Health Facilities | 2 | 2016 | 79 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 1983 | 157 | 0.060 |
Why?
|
| Netherlands | 2 | 1997 | 83 | 0.060 |
Why?
|
| Retroviridae | 1 | 1983 | 332 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 6311 | 0.060 |
Why?
|
| Suicide | 1 | 2005 | 180 | 0.060 |
Why?
|
| Urban Health | 1 | 2003 | 75 | 0.060 |
Why?
|
| Prejudice | 1 | 2003 | 57 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 2992 | 0.050 |
Why?
|
| Data Collection | 3 | 2021 | 620 | 0.050 |
Why?
|
| Cardiovascular Diseases | 3 | 2011 | 2195 | 0.050 |
Why?
|
| Postnatal Care | 2 | 2012 | 47 | 0.050 |
Why?
|
| Animals | 6 | 2021 | 59536 | 0.050 |
Why?
|
| Organ Size | 1 | 2003 | 690 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 945 | 0.050 |
Why?
|
| California | 1 | 2022 | 208 | 0.050 |
Why?
|
| Environment | 1 | 2002 | 190 | 0.050 |
Why?
|
| Pharmacovigilance | 1 | 2021 | 12 | 0.050 |
Why?
|
| Epigenomics | 1 | 2022 | 266 | 0.050 |
Why?
|
| Antigens, Viral | 2 | 2018 | 471 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 2 | 2004 | 30 | 0.050 |
Why?
|
| Statistics as Topic | 4 | 1995 | 445 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 1099 | 0.050 |
Why?
|
| Saliva | 2 | 2014 | 231 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 915 | 0.050 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2020 | 45 | 0.050 |
Why?
|
| Causality | 2 | 2004 | 178 | 0.050 |
Why?
|
| Health Status Indicators | 2 | 2007 | 224 | 0.050 |
Why?
|
| Labor Stage, Second | 2 | 2010 | 15 | 0.050 |
Why?
|
| Birthing Centers | 1 | 2019 | 10 | 0.050 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2019 | 38 | 0.050 |
Why?
|
| Minority Groups | 1 | 2022 | 322 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 409 | 0.040 |
Why?
|
| Penicillin G Benzathine | 1 | 2019 | 16 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2012 | 467 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 90 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2018 | 23 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2019 | 166 | 0.040 |
Why?
|
| Life Style | 1 | 2003 | 612 | 0.040 |
Why?
|
| Labor Stage, First | 2 | 2010 | 6 | 0.040 |
Why?
|
| Forecasting | 2 | 2020 | 694 | 0.040 |
Why?
|
| Neoplasms | 3 | 2016 | 15193 | 0.040 |
Why?
|
| Age Factors | 4 | 2015 | 5377 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1148 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 342 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2018 | 266 | 0.040 |
Why?
|
| Switzerland | 1 | 1997 | 21 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 3254 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 856 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2021 | 649 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 702 | 0.040 |
Why?
|
| Government Agencies | 1 | 2016 | 21 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2016 | 50 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2011 | 233 | 0.030 |
Why?
|
| Physician's Role | 1 | 1998 | 238 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 1371 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2016 | 90 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 1320 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 1328 | 0.030 |
Why?
|
| House Calls | 1 | 2015 | 39 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 41 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 703 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 1399 | 0.030 |
Why?
|
| Hospitals, District | 2 | 2006 | 6 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 289 | 0.030 |
Why?
|
| Aged | 1 | 2020 | 70117 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2013 | 2803 | 0.030 |
Why?
|
| Colposcopy | 1 | 1994 | 78 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2017 | 298 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 138 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 3639 | 0.030 |
Why?
|
| Obstetrical Forceps | 1 | 1994 | 8 | 0.030 |
Why?
|
| Students | 1 | 2017 | 324 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 435 | 0.030 |
Why?
|
| Publishing | 1 | 2016 | 220 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 541 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1994 | 31 | 0.030 |
Why?
|
| Models, Educational | 1 | 2014 | 95 | 0.030 |
Why?
|
| Abortion, Induced | 2 | 2004 | 91 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2013 | 16 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2015 | 298 | 0.030 |
Why?
|
| Nurse Midwives | 1 | 2013 | 9 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 210 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 3203 | 0.030 |
Why?
|
| Blood Banks | 1 | 2013 | 33 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 2055 | 0.030 |
Why?
|
| Contraindications | 1 | 1993 | 150 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 1993 | 27 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1995 | 482 | 0.030 |
Why?
|
| Cell Phone | 1 | 2013 | 45 | 0.030 |
Why?
|
| Fetal Mortality | 1 | 2012 | 8 | 0.030 |
Why?
|
| United Kingdom | 1 | 1993 | 257 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 978 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 2669 | 0.030 |
Why?
|
| Feedback | 1 | 1993 | 198 | 0.030 |
Why?
|
| Scotland | 1 | 1991 | 38 | 0.030 |
Why?
|
| Periodontics | 1 | 2011 | 2 | 0.030 |
Why?
|
| Attitude | 1 | 2012 | 159 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2004 | 99 | 0.020 |
Why?
|
| Civil Defense | 1 | 2010 | 13 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 213 | 0.020 |
Why?
|
| Information Systems | 2 | 1989 | 54 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1945 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 285 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 66 | 0.020 |
Why?
|
| Magnesium Sulfate | 1 | 2010 | 39 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 59 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1990 | 24 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1990 | 82 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 13 | 0.020 |
Why?
|
| Placenta, Retained | 1 | 2009 | 13 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 1990 | 98 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3869 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2009 | 23 | 0.020 |
Why?
|
| Temperament | 1 | 2009 | 21 | 0.020 |
Why?
|
| Telemedicine | 1 | 2015 | 471 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 1990 | 101 | 0.020 |
Why?
|
| Psychology, Child | 1 | 2009 | 43 | 0.020 |
Why?
|
| Emergencies | 1 | 2010 | 202 | 0.020 |
Why?
|
| Bolivia | 1 | 2008 | 21 | 0.020 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 64 | 0.020 |
Why?
|
| Sutures | 1 | 2009 | 86 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 1988 | 39 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 181 | 0.020 |
Why?
|
| Teaching | 1 | 2010 | 243 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 754 | 0.020 |
Why?
|
| Japan | 1 | 1989 | 227 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1988 | 168 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1990 | 235 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 706 | 0.020 |
Why?
|
| Sex Factors | 2 | 1990 | 2139 | 0.020 |
Why?
|
| Decision Trees | 1 | 1988 | 178 | 0.020 |
Why?
|
| Defensive Medicine | 1 | 2007 | 8 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2010 | 414 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 1987 | 34 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1987 | 25 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 431 | 0.020 |
Why?
|
| Benin | 1 | 2006 | 2 | 0.020 |
Why?
|
| Women, Working | 1 | 1986 | 15 | 0.020 |
Why?
|
| Women | 1 | 1986 | 27 | 0.020 |
Why?
|
| State Government | 1 | 2006 | 33 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 244 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 415 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 120 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2005 | 83 | 0.020 |
Why?
|
| Death Certificates | 1 | 2004 | 17 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 295 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 188 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2004 | 32 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 585 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 3536 | 0.020 |
Why?
|
| Fetal Growth Retardation | 1 | 2006 | 194 | 0.020 |
Why?
|
| Physicians | 1 | 2013 | 882 | 0.020 |
Why?
|
| Menarche | 1 | 1984 | 50 | 0.020 |
Why?
|
| Adsorption | 1 | 1983 | 46 | 0.020 |
Why?
|
| Aftercare | 1 | 2006 | 259 | 0.020 |
Why?
|
| Haplorhini | 1 | 1983 | 130 | 0.010 |
Why?
|
| Seizures | 1 | 1990 | 989 | 0.010 |
Why?
|
| Virus Cultivation | 1 | 1983 | 70 | 0.010 |
Why?
|
| Chiroptera | 1 | 1983 | 45 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 2003 | 6 | 0.010 |
Why?
|
| Rubella Vaccine | 1 | 1983 | 2 | 0.010 |
Why?
|
| Health Priorities | 1 | 2003 | 40 | 0.010 |
Why?
|
| Body Height | 1 | 1984 | 231 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2003 | 68 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2006 | 583 | 0.010 |
Why?
|
| Dogs | 1 | 1983 | 1155 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 222 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 509 | 0.010 |
Why?
|
| Eclampsia | 1 | 2000 | 28 | 0.010 |
Why?
|
| Pregnancy Trimesters | 1 | 2000 | 36 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 233 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2001 | 250 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12221 | 0.010 |
Why?
|
| Greece | 1 | 1995 | 22 | 0.010 |
Why?
|
| Indonesia | 1 | 1995 | 17 | 0.010 |
Why?
|
| Sweden | 1 | 1995 | 70 | 0.010 |
Why?
|
| MEDLINE | 1 | 1995 | 36 | 0.010 |
Why?
|
| Norway | 1 | 1995 | 30 | 0.010 |
Why?
|
| Italy | 1 | 1995 | 236 | 0.010 |
Why?
|
| Rats | 1 | 1983 | 6086 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 4367 | 0.010 |
Why?
|
| Cost Control | 1 | 1986 | 48 | 0.000 |
Why?
|
| Allergens | 1 | 1987 | 247 | 0.000 |
Why?
|
| Object Attachment | 1 | 1985 | 58 | 0.000 |
Why?
|
| Mice | 1 | 1983 | 34495 | 0.000 |
Why?
|